Ontology highlight
ABSTRACT: Purpose
Immune-related pneumonitis (IRP) has attracted extensive attention, owing to its increased mortality rate. Conventional chemotherapy (C) has been considered as an immunosuppressive agent and may thus reduce IRP's risk when used in combination with PD-1/L1 inhibitors. This study aimed to assess the risk of IRP with PD-1/L1 inhibitors plus chemotherapy (I+C) versus PD-1/L1 inhibitors alone (I) in solid cancer treatment.Method
Multiple databases were searched for RCTs before January 2021. This NMA was performed among I+C, I, and C to investigate IRP's risk. Subgroup analysis was carried out on the basis of different PD-1/L1 inhibitors and cancer types.Results
Thirty-one RCTs (19,624 patients) were included. The I+C group exhibited a lower risk of IRP in any gra
SUBMITTER: Long YX
PROVIDER: S-EPMC8774972 | biostudies-literature | 2022 Jan
REPOSITORIES: biostudies-literature